Functional brain changes after alternative pharmacological interventions in posttraumatic stress disorder: A systematic review of clinical trials

Abstract Background Posttraumatic stress disorder (PTSD) is a complex and heterogeneous mental health condition that can develop after exposure to a traumatic event. Clinical trials have used alternative pharmacological agents to treat PTSD, but their associated neural correlates remain unclear. The...

Full description

Bibliographic Details
Main Authors: Shahab Lotfinia, Amin Afshar, Aram Yaseri, Miranda Olff, Yann Quidé
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:Brain and Behavior
Subjects:
Online Access:https://doi.org/10.1002/brb3.3292
_version_ 1797336367700639744
author Shahab Lotfinia
Amin Afshar
Aram Yaseri
Miranda Olff
Yann Quidé
author_facet Shahab Lotfinia
Amin Afshar
Aram Yaseri
Miranda Olff
Yann Quidé
author_sort Shahab Lotfinia
collection DOAJ
description Abstract Background Posttraumatic stress disorder (PTSD) is a complex and heterogeneous mental health condition that can develop after exposure to a traumatic event. Clinical trials have used alternative pharmacological agents to treat PTSD, but their associated neural correlates remain unclear. The present systematic review aims to summarize the changes in brain function associated with the use of these alternative pharmacological agents in PTSD. Methods Clinical trials using functional magnetic resonance imaging, either at rest or during the performance of tasks, were included if they compared the effects of alternative pharmacological agents between PTSD patients and either trauma‐exposed controls or never‐exposed healthy controls. Results Sixteen studies were included, of which 11 used intranasal oxytocin, 2 used hydrocortisone, and 3 used delta‐9‐tetrahydrocannabinol (THC). Oxytocin administration was associated with the normalization of functional connectivity between the ventromedial prefrontal cortex and amygdala as well as enhanced the function of brain regions specifically involved in emotion processing (e.g., amygdala), working memory (e.g., dorsolateral prefrontal cortex), and reward (e.g., putamen). Hydrocortisone did not influence brain function at rest or during the performance of an autobiographical memory task, whereas THC was associated with the reduction of the amygdala and increased medial prefrontal cortex activation. Conclusions This systematic review identified preliminary evidence for normalizing brain function after the use of alternative pharmacological agents. Importantly, sex‐specific differences were noted, in particular when using oxytocin, that will require further investigation.
first_indexed 2024-03-08T08:53:24Z
format Article
id doaj.art-703d87cbf32f40199b8d761c0b3b71b4
institution Directory Open Access Journal
issn 2162-3279
language English
last_indexed 2024-03-08T08:53:24Z
publishDate 2023-12-01
publisher Wiley
record_format Article
series Brain and Behavior
spelling doaj.art-703d87cbf32f40199b8d761c0b3b71b42024-02-01T07:45:36ZengWileyBrain and Behavior2162-32792023-12-011312n/an/a10.1002/brb3.3292Functional brain changes after alternative pharmacological interventions in posttraumatic stress disorder: A systematic review of clinical trialsShahab Lotfinia0Amin Afshar1Aram Yaseri2Miranda Olff3Yann Quidé4Department of Clinical Psychology, School of Medicine Shahid Beheshti University of Medical Science Tehran IranFaculty of Medicine Qazvin University of Medical Science Qazvin IranSchool of Medicine Shahid Beheshti University of Medical Science Tehran IranDepartment of Psychiatry Amsterdam University Medical Centers Location AMC, Amsterdam Public Health Amsterdam The NetherlandsNeuroRecovery Research Hub, School of Psychology The University of New South Wales (UNSW) Sydney Sydney New South Wales AustraliaAbstract Background Posttraumatic stress disorder (PTSD) is a complex and heterogeneous mental health condition that can develop after exposure to a traumatic event. Clinical trials have used alternative pharmacological agents to treat PTSD, but their associated neural correlates remain unclear. The present systematic review aims to summarize the changes in brain function associated with the use of these alternative pharmacological agents in PTSD. Methods Clinical trials using functional magnetic resonance imaging, either at rest or during the performance of tasks, were included if they compared the effects of alternative pharmacological agents between PTSD patients and either trauma‐exposed controls or never‐exposed healthy controls. Results Sixteen studies were included, of which 11 used intranasal oxytocin, 2 used hydrocortisone, and 3 used delta‐9‐tetrahydrocannabinol (THC). Oxytocin administration was associated with the normalization of functional connectivity between the ventromedial prefrontal cortex and amygdala as well as enhanced the function of brain regions specifically involved in emotion processing (e.g., amygdala), working memory (e.g., dorsolateral prefrontal cortex), and reward (e.g., putamen). Hydrocortisone did not influence brain function at rest or during the performance of an autobiographical memory task, whereas THC was associated with the reduction of the amygdala and increased medial prefrontal cortex activation. Conclusions This systematic review identified preliminary evidence for normalizing brain function after the use of alternative pharmacological agents. Importantly, sex‐specific differences were noted, in particular when using oxytocin, that will require further investigation.https://doi.org/10.1002/brb3.3292functional magnetic resonance imaginghydrocortisoneoxytocinposttraumatic stress disorder
spellingShingle Shahab Lotfinia
Amin Afshar
Aram Yaseri
Miranda Olff
Yann Quidé
Functional brain changes after alternative pharmacological interventions in posttraumatic stress disorder: A systematic review of clinical trials
Brain and Behavior
functional magnetic resonance imaging
hydrocortisone
oxytocin
posttraumatic stress disorder
title Functional brain changes after alternative pharmacological interventions in posttraumatic stress disorder: A systematic review of clinical trials
title_full Functional brain changes after alternative pharmacological interventions in posttraumatic stress disorder: A systematic review of clinical trials
title_fullStr Functional brain changes after alternative pharmacological interventions in posttraumatic stress disorder: A systematic review of clinical trials
title_full_unstemmed Functional brain changes after alternative pharmacological interventions in posttraumatic stress disorder: A systematic review of clinical trials
title_short Functional brain changes after alternative pharmacological interventions in posttraumatic stress disorder: A systematic review of clinical trials
title_sort functional brain changes after alternative pharmacological interventions in posttraumatic stress disorder a systematic review of clinical trials
topic functional magnetic resonance imaging
hydrocortisone
oxytocin
posttraumatic stress disorder
url https://doi.org/10.1002/brb3.3292
work_keys_str_mv AT shahablotfinia functionalbrainchangesafteralternativepharmacologicalinterventionsinposttraumaticstressdisorderasystematicreviewofclinicaltrials
AT aminafshar functionalbrainchangesafteralternativepharmacologicalinterventionsinposttraumaticstressdisorderasystematicreviewofclinicaltrials
AT aramyaseri functionalbrainchangesafteralternativepharmacologicalinterventionsinposttraumaticstressdisorderasystematicreviewofclinicaltrials
AT mirandaolff functionalbrainchangesafteralternativepharmacologicalinterventionsinposttraumaticstressdisorderasystematicreviewofclinicaltrials
AT yannquide functionalbrainchangesafteralternativepharmacologicalinterventionsinposttraumaticstressdisorderasystematicreviewofclinicaltrials